lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif
- PMID: 2752424
- DOI: 10.1016/0092-8674(89)90404-2
lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif
Abstract
We have characterized a transcription unit at chromosome band 19p13 that lies at the site of a chromosomal translocation breakpoint in T cell acute lymphoblastic leukemia. The lyl-1 gene is structurally altered following a t(7;19) translocation, resulting in its head-to-head juxtaposition with the T cell receptor C beta gene and truncation of lyl-1 RNA. The predicted protein product of the lyl-1 gene contains a potential helix-loop-helix DNA binding motif also found in several proteins involved in the control of cellular proliferation and differentiation: all members of the Myc family, MyoD1, myogenin, the Drosophila achaete-scute, twist, and daughterless proteins, and two recently described immunoglobulin enhancer binding proteins. The implication of lyl-1 in cellular transformation suggests that other proteins containing similar DNA binding motifs may also be involved with neoplastic transformation in various cellular lineages.
Similar articles
-
Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system.Oncogene. 1991 Feb;6(2):187-94. Oncogene. 1991. PMID: 2000219
-
Structure, chromosome mapping, and expression of the mouse Lyl-1 gene.Oncogene. 1991 Jun;6(6):961-8. Oncogene. 1991. PMID: 2067848
-
Chromosomal translocation involving the beta T cell receptor gene in acute leukemia.J Exp Med. 1988 Feb 1;167(2):682-7. doi: 10.1084/jem.167.2.682. J Exp Med. 1988. PMID: 3162254 Free PMC article.
-
Helix-loop-helix genes translocated in lymphoid leukemia.Trends Biochem Sci. 1991 Sep;16(9):330-3. doi: 10.1016/0968-0004(91)90137-k. Trends Biochem Sci. 1991. PMID: 1949153 Review.
-
Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia.Semin Cancer Biol. 1993 Dec;4(6):387-99. Semin Cancer Biol. 1993. PMID: 8142624 Review.
Cited by
-
An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity against CD7-positive cells.Leuk Res. 2021 Sep;108:106626. doi: 10.1016/j.leukres.2021.106626. Epub 2021 May 18. Leuk Res. 2021. PMID: 34062328 Free PMC article.
-
Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.Proc Natl Acad Sci U S A. 1990 Jun;87(12):4722-6. doi: 10.1073/pnas.87.12.4722. Proc Natl Acad Sci U S A. 1990. PMID: 2112746 Free PMC article.
-
Oncogenic Enhancers in Leukemia.Blood Cancer Discov. 2024 Sep 3;5(5):303-317. doi: 10.1158/2643-3230.BCD-23-0211. Blood Cancer Discov. 2024. PMID: 39093124 Review.
-
An analysis of vertebrate mRNA sequences: intimations of translational control.J Cell Biol. 1991 Nov;115(4):887-903. doi: 10.1083/jcb.115.4.887. J Cell Biol. 1991. PMID: 1955461 Free PMC article. Review.
-
Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma.Mol Cell Biol. 1992 Sep;12(9):4186-96. doi: 10.1128/mcb.12.9.4186-4196.1992. Mol Cell Biol. 1992. PMID: 1508213 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous